Principal
Avalere Health
Silver Spring, Maryland
Kelly L. George, PhD, RAC leads the Regulatory Strategy and FDA Policy Team at Avalere. She supports clients in navigating the FDA strategy and policy environment for the development and lifecycle of drugs and biologics with a particular focus on and experience with the regulations and oversight of biosimilar products.
Kelly applies her scientific and regulatory expertise toward the design and implementation of overarching drug development strategies to connect the dots between regulatory decisions and market access priorities while balancing the impact on patient access, time to market entry, and the creation of a sustainable market. She is passionate about helping clients ensure the policies guiding development of cutting-edge technologies are both efficient and scientifically founded to allow for the highest quality products to reach target patients.
Trained as a bioanalytical chemist, Kelly previously provided business strategy, product development and in-depth market analysis for pipeline technologies at the Innovation Institute and Fourth River Solutions.
Disclosure information not submitted.
Regulatory and Policy Updates: What is Happening and What it Means for You
Friday, August 18, 2023
1:10 PM – 1:55 PM East Coast USA Time